None
Quote | Genmab A/S (NYSE:GMAB)
Last: | $ |
---|---|
Change Percent: | -2.01% |
Open: | $24.00 |
Close: | $23.84 |
High: | $24.01 |
Low: | $23.83 |
Volume: | 215,311 |
Last Trade Date Time: | 02/12/2020 04:43:03 pm |
News | Genmab A/S (NYSE:GMAB)
A look at the top 10 most actives in the United States Innovative Eyewear Inc. (LUCY) rose 78.0% to $0.58749 on volume of 130,454,575 shares Ocean Power Technologies Inc. (OPTT) rose 29.6% to $0.2073 on volume of 51,927,154 shares Cosmos Health Inc. (COSM) rose 64.9% to $1.12 on volume of...
2024-06-28 09:29:56 ET More on AbbVie, Genmab, etc. AbbVie: 5 Reasons That Make A Buy Case AbbVie, Inc. (ABBV) Goldman Sachs 45th Annual Global Healthcare Conference (Transcript) AbbVie: Turnaround Lurking After The Correction Pain (Upgrade) AbbVie buys bowel...
Message Board Posts | Genmab A/S (NYSE:GMAB)
Subject | By | Source | When |
---|---|---|---|
Emylers: GMXAY Financials 07/16/2014 18:58:03 Genmab A/S Period Ending Total Revenue Cost of Revenue | Emylers | investorshangout | 07/16/2014 11:57:58 PM |
chartguy89: GMXAY 22.23 Stock Charts $GMXAY 1 Month Chart | chartguy89 | investorshangout | 03/07/2014 5:48:58 PM |
chartguy89: GMXAY Stock Charts Last: -0.44 Wednesday, February 26, 2014 at 12:53:33 PM $GMXAY | chartguy89 | investorshangout | 02/26/2014 5:53:45 PM |
News, Short Squeeze, Breakout and More Instantly...
A look at the top 10 most actives in the United States Innovative Eyewear Inc. (LUCY) rose 78.0% to $0.58749 on volume of 130,454,575 shares Ocean Power Technologies Inc. (OPTT) rose 29.6% to $0.2073 on volume of 51,927,154 shares Cosmos Health Inc. (COSM) rose 64.9% to $1.12 on volume of...
Company Announcement Positive CHMP opinion based on results from the Phase 1/2 EPCORE ® NHL-1 study FL is the second most common type of NHL and accounts for approximately 20-30 percent of all global cases If approved, epcoritamab (TEPKINLY ® ...
2024-06-27 09:00:08 ET Kaveri Pohlman from BTIG issued a price target of $47.00 for GMAB on 2024-06-27 07:34:00. The adjusted price target was set to $47.00. At the time of the announcement, GMAB was trading at $25.67. The overall price target consensus is at $41.80 with...